ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat Discomfort

▴ ICPA Health Products
The product will be available at leading pharmacies nationwide, as well as through popular e-pharmacies, ensuring easy accessibility for all individuals seeking effective relief for oral and throat discomfort.

Mumbai, Feb 2024: India’s leading Pharma Company in the oral healthcare segment - ICPA Health Products Ltd (ICPA) has introduced its newest oral healthcare solution – Coolora Spray. Specifically designed as a mouth spray, the product effectively addresses inflammatory and painful conditions in the mouth and throat, including post-tonsillectomy pain control, pharyngitis, laryngitis, oral mucositis, mouth ulcers and burning sensations. Coolora Spray proves highly effective in reaching the tonsils and posterior pharyngeal wall, providing effective relief within just two minutes of application. Packed in a convenient 25 ml High-Density Polyethylene (HDPE) bottle equipped with a metered dose valve pump, a single spray delivers 250 micrograms of Benzydamine Hydrochloride.

ICPA has expanded its product range with the introduction of Coolora spray, alongside the existing Coolora gargle. A spray form of delivery brings unique benefits, especially in easing post-tonsillectomy surgical pain for patients who struggle with gargling after the surgery. Additionally, for children who have difficulty gargling, the spray would be more suitable because it eliminates the chances of gargle swallowing. This move reflects ICPA’s commitment to making healthcare more accessible for everyone.

The active ingredient in Coolora Spray, Benzydamine Hydrochloride 0.15 per cent, belongs to the category of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Operating in the throat and mouth, the spray effectively alleviates pain and inflammation by inhibiting the synthesis of pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β).

Coolora Spray is suitable for both adults and children, with varying recommended dosages. For adults, it is advised to spray 4 to 8 puffs onto the affected area every 1½ to 3 hours. Children aged 6 to 12 years should administer four puffs, while those under 6 years old should apply one puff for every 4 kilograms of body weight, up to a maximum of four puffs, every 1½ to 3 hours.

The product will be available at leading pharmacies nationwide, as well as through popular e-pharmacies, ensuring easy accessibility for all individuals seeking effective relief for oral and throat discomfort.

Company name: ICPA Health Products Ltd.

Product name: Coolora Spray

Qty.: 25 ml

MRP: Rs.190/-

About ICPA Health Products (ICPA): -

ICPA Health Products Ltd. is the leading Indian manufacturer in the oral healthcare segment with well-known, trusted products like Thermoseal and Hexidine. Headquartered in Mumbai, the 50 year old company has an international presence in South-East Asia, Middle-East, UK, Australia and French West Africa. In addition to dental products, ICPA also specializes in herbal and cosmetic products all of which are manufactured at its state-of-the-art, facility certified by the EU, WHO GMP and ISO in Gujarat. ICPA enjoys the franchise of around 70 per cent of India’s dental surgeons along with a significant number of ENTs and cancer specialists in the subcontinent.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Karan Johar and Guneet Monga Kapoor’s 'Gyaarah Gyaarah' trailer breaks time barriers on ZEE5July 26, 2024
If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Investing in India’s Path to a Healthier and Brighter FutureJuly 26, 2024
Your Medication Could Be Useless This Summer: How Heat Waves Affect Drug SafetyJuly 26, 2024
Innovative Approach to Adolescent Weight Loss: Combining Meal-Replacement Therapy with Financial IncentivesJuly 26, 2024
Promoting School Cardiopulmonary Resuscitation (CPR) Program in India: A Step Towards Saving LivesJuly 26, 2024
Education Budget 2024: A Step Towards Better Learning : Gargi Limaye July 25, 2024
AI assistant shows great promise in cataract care pathwayJuly 25, 2024
Publishing Powerhouse Devangini : A Force of Resilience and Empowerment in LiteratureJuly 25, 2024
Alarm rings in Asia Pacific for not making U-equals-U and HIV prevention accessible to allJuly 25, 2024
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular DiseasesJuly 24, 2024
Nurturing Souls revolutionises 1000 Child-Parent Relationships for Better Career Choices & improved Mental HealthJuly 24, 2024
How to Improve Sleep Quality in Adolescents: Insights from a New StudyJuly 24, 2024
Tragic Nipah Virus Death of 14-Year-Old in Kerala: What You Need to KnowJuly 24, 2024
India Inaugurates First Overseas Jan Aushadi Kendra in MauritiusJuly 24, 2024
Budget Reaction Quote - Ms. Deepshikha Sharma, CEO, Sharp Sight Eye HospitalsJuly 23, 2024
Quote to be attributed to Mr. Jatinder Paul Singh, CEO & Co - Founder of Viacation Tourism:July 23, 2024
Budget Reaction by Anjan Bose, Founding Secretary General, NATHEALTH July 23, 2024
Mr. Niranjan Kirloskar, Managing Director, Fleetguard Filters Private Limited- BUDGET REACTIONJuly 23, 2024